|
|
 |
|
| Test Name: | KRAS Gene Hotspot Mutation Detection (exons 2-4) |
| Compliance: | LDT |
| Test Description: | KRAS is commonly mutated and thereby activated in various human cancers, including lung adenocarcinoma, mucinous adenoma, ductal carcinoma of the pancreas, and colorectal carcinoma. Activating mutations in the KRAS gene are found in 30–40% of colorectal tumors and are associated with poor response to anti-EGFR therapies. Thus, KRAS mutation status can predict which patient may or may not benefit from anti-EGFR therapy. |
| Methodology: | PCR-Sanger sequencing analysis of mutations in exons 2-4 of the KRAS gene |
| Gene Name: | KRAS |
| Protein Name: | |
| Specimen Requirements: | FFPE tissue slides (4µm) |
| Storage Condition: | Ambient Temperature |
| Turn Around Time: | 5 working days from day of specimen received |
| OMIM: | |
| Genetic Home Reference: | |
|
|
|
|
|
|
|
|
Shipping & Billing Information
|
Non-disclosure and Complaints
All data/information generated from within/related to HKMPDC and our customers are treated in strict confidence in accordance with the Personal Data (Privacy) Ordinance of Hong Kong. If you have a complaint, please contact us at the (852) 2986 1213 or email us at contact@hk-mpdc.com. All communications with HKMPDC would be dealt with in strict confidence.
Notice of Privacy Practices
This notice describes how medical information about you may be used and disclosed.
Personal health information or related information released to HKMPDC relating to the services requested may be subjected to re-disclosure by HKMPDC to health care providers, such as doctors, nurses, and others involved in the delivery of the services.
We may also disclose medical information about you to authorised public health or government officials for public health activities as required by law and accreditation body.
Copyright © 2013 香港分子病理檢驗中心 Hong Kong Molecular Pathology Diagnostic Centre Limited (HKMPDC). All Rights Reserved.
Information Updated 1 July, 2023.
|
|
|
|
